Hairy Cell Leukemia - 25 Studies Found
| Completed |
: Therapy Optimisation for the Treatment of Hairy Cell Leukemia : Hairy Cell Leukemia : 2014-04-30 : Drug: Cladribine s.c. injection, HCL treatment Patients with hairy cell leukemia and the need for treatm |
| Terminated |
: Retreatment Protocol for BL22 Immunotherapy in Relapsed or Refractory Hairy Cell Leukemia : Hairy Cell Leukemia : 2009-06-17 : Drug: BL22 (CAT-3888) 30 micrograms/kg intravenous over 30 minutes every other day (QOD) on days 1, 3, 5 |
| Active, not recruiting |
: LMB-2 to Treat Hairy Cell Leukemia : Hairy Cell Leukemia : 2006-05-03 : Drug: Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin LMB-2 Infusion: 40 micro-g/Kg will be infused in 50 ml of 0. |
| Completed |
: Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia : Hairy Cell Leukemia : 2009-06-17 :
|
| Completed |
: Rituximab in Hairy Cell Leukemia: a Multicenter Retrospective Study : Hairy-cell Leukemia : 2016-08-25 : Other: Data collection |
| Completed |
: Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia : Hairy Cell Leukemia : 2010-01-29 :
|
| Completed |
: A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia : Hairy Cell Leukemia : 1999-11-03 : Drug: Roferon-A |
| Active, not recruiting |
: BRAF Inhibitor, Vemurafenib, in Patients With Relapsed or Refractory Hairy Cell Leukemia : Hairy Cell Leukemia : 2012-10-17 : Drug: Vemurafenib Patients will receive vemurafenib at a dose of 960mg orally b.i.d. continuously in cyc |
| Recruiting |
: Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia :
|
| Completed |
: Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia With Cladribine Plus Rituximab : Hairy Cell Leukemia (HCL) : 2014-05-21 : Drug: 2CdA +/- Rituximab Cladribine 0.14 mg/kg daily subcutaneous bolus injection Rituximab 375 mg/m |